Patent ID: 11944612
Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The capsule dosage form of claim 4 comprising:
(i) from about 65% to about 86% w/w of the crystalline ansolvate form compound 1;
(ii) from about 2% to about 6% w/w a binder;
(iii) from about 3.5% to about 25% w/w an insoluble filler, or 2.5% to 25% w/w of soluble filler, or 2.5% to 25% of a combination of soluble or insoluble filler;
(iv) from about 2% to 6% w/w a disintegrant; and
(iv) from about 0.5% to about 1.5% w/w a lubricant.